This article has been cited by
1Mobile App Design, Development, and Publication for Adverse Drug Reaction Assessments of Causality, Severity, and Preventability
Muslimah Ithnin,Mohd Dzulkhairi Mohd Rani,Zuraidah Abd Latif,Paveethra Kani,Asmalita Syaiful,Khairun Nain Nor Aripin,Tengku Amatullah Madeehah Tengku Mohd
JMIR mHealth and uHealth.2017;5(5)e78
[DOI]
2Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR
Lateef M. Khan,Sameer E. Al-Harthi,Omar I. Saadah
Saudi Pharmaceutical Journal.2013;21(3)261
[DOI]
3A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital
M. Shamna,C. Dilip,M. Ajmal,P. Linu Mohan,C. Shinu,C.P. Jafer,Yahiya Mohammed
Saudi Pharmaceutical Journal.2014;22(4)303
[DOI]
4Benefits of Medication Antidote Signals for the Detection of Potential Adverse Drug Reactions over Contemporary Methods of Pharmacovigilance in Hospitalized Children
Lateef M. Khan,Fatemah O. Kamel,Huda M. Alkreathy,Sameer E. Al-Harthi,Omar I. Saadah,Abdel-Moneim M. Osman,Mohammad A. Allibaih
International Journal of Pharmacology.2017;13(1)64
[DOI]
5Evidence for neurotoxicity associated with amoxicillin in juvenile rats
O Atli,U Demir-Ozkay,S Ilgin,TH Aydin,EN Akbulut,E Sener
Human & Experimental Toxicology.2016;35(8)866
[DOI]
6Adverse Drug Events and Reactions Managed by Medical Toxicologists: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010–2016
Gillian A. Beauchamp,Alexandra Amaducci,Marna Rayl Greenberg,Matthew Meyers,Matthew Cook,Robert D. Cannon,Kenneth D. Katz,Yaron Finkelstein
Journal of Medical Toxicology.2019;15(4)262
[DOI]
7Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study
J. Kurian,J. Mathew,K. Sowjanya,K. R. K. Chaitanya,M. Ramesh,J. Sebastian,D. Narayanappa
The Indian Journal of Pediatrics.2016;83(5)414
[DOI]
8Evaluation of Reported Adverse Drug Reactions in Antibiotic Usage: A Retrospective Study From a Tertiary Care Hospital, Malaysia
Ann L. Arulappen,Monica Danial,Syed A. S. Sulaiman
Frontiers in Pharmacology.2018;9(5)414
[DOI]
9The practice of off label prescribing and associated adverse drug reactions in pediatric inpatients in a tertiary care hospital in India
Rebecca Rajan,Sharlin M. Peter,Vincey M. Kurian,Roohinaz Ansari,Sunita Pawar,Vijay Kalrao
Journal of Pharmaceutical Health Services Research.2019;10(1)29
[DOI]
10Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
Alan O. Vázquez-Alvarez,Lorena Michele Brennan-Bourdon,Ana Rosa Rincón-Sánchez,María Cristina Islas-Carbajal,Selene G. Huerta-Olvera
BMC Pharmacology and Toxicology.2017;18(1)29
[DOI]
11A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily
Chiara Nasso,Anna Mecchio,Michelangelo Rottura,Mariella Valenzise,Francesca Menniti-Ippolito,Paola Maria Cutroneo,Violetta Squadrito,Francesco Squadrito,Giovanni Pallio,Natasha Irrera,Vincenzo Arcoraci,Domenica Altavilla
Frontiers in Pharmacology.2020;11(1)29
[DOI]
12Health-related quality of life in children with cutaneous adverse drug reactions
Blanca R. Del Pozzo-Magaña,Alejandro Lazo-Langner,Michael J. Rieder
Pediatric Dermatology.2017;34(6)e341
[DOI]
13Health-related quality of life in children with cutaneous adverse drug reactions
Mohannad Abu-Hilal,Neil Shear
Pediatric Dermatology.2019;34(6)785
[DOI]
14Health-related quality of life in children with cutaneous adverse drug reactions
Angelica Intini,Donato Bonifazi,Giovanni Migliaccio
Pediatric Dermatology.2020;34(6)785
[DOI]
15An Observational Study to Evaluate the Adverse Drug Reactions Secondary to the Use of Anti-Microbial Agents in Patients Admitted to Surgery Ward at Tertiary Care Hospital
Sumit Kumar,Bhagya Sattigeri
SSRN Electronic Journal.2019;34(6)785
[DOI]
16Pattern of Adverse Drug Reactions in Children Attending the Department of Pediatrics in a Tertiary Care Center: A Prospective Observational Study
Kishour Kumar Digra,Aakash Pandita,G. S. Saini,Rajni Bharti
Clinical Medicine Insights: Pediatrics.2015;9(6)CMPed.S29493
[DOI]
17Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
Rosliana Rosli,Ahmad Fauzi Dali,Noorizan Abd. Aziz,Long Chiau Ming,Mohamed Mansor Manan
Frontiers in Pharmacology.2017;8(6)CMPed.S29493
[DOI]
18Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
Bhanu Pratap Singh Rawat,Fei Li,Hong Yu
Frontiers in Pharmacology.2019;8(6)2547
[DOI]
19Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay – a systematic review
Lateef Mohiuddin Khan
European Journal of Clinical Pharmacology.2013;69(12)1985
[DOI]
20Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events
Elena Genova,Federica Cavion,Marianna Lucafò,Luigina De Leo,Marco Pelin,Gabriele Stocco,Giuliana Decorti
World Journal of Stem Cells.2019;11(12)1020
[DOI]
21Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study
Niccolò Lombardi,Giada Crescioli,Alessandra Bettiol,Ettore Marconi,Antonio Vitiello,Roberto Bonaiuti,Anna Maria Calvani,Stefano Masi,Ersilia Lucenteforte,Alessandro Mugelli,Lisa Giovannelli,Alfredo Vannacci
BMC Pharmacology and Toxicology.2018;19(1)1020
[DOI]
22Adverse Drug Events and Reactions Managed by Medical Toxicologists: an Analysis of the Toxicology Investigators Consortium (ToxIC) Registry, 2010–2016
Gillian A. Beauchamp,Alexandra Amaducci,Marna Rayl Greenberg,Matthew Meyers,Matthew Cook,Robert D. Cannon,Kenneth D. Katz,Yaron Finkelstein
Journal of Medical Toxicology.2019;15(4)262
[DOI]
23A study on adverse drug reactions in a tertiary care hospital of Northeast India
Ratan J. Lihite,Mangala Lahkar,Sukirti Das,Debeeka Hazarika,Murali Kotni,Mudasir Maqbool,Swapna Phukan
Alexandria Journal of Medicine.2017;53(2)151
[DOI]
24Suspected Overlap Between Serotonin Syndrome and Neuroleptic Malignant Syndrome in a Child Treated With Metoclopramide?
Marine Aussedat,Annie Lavoie,Jean-François Bussières,Niina Kleiber
The Journal of Pediatric Pharmacology and Therapeutics.2020;25(6)552
[DOI]
25Surveillance study on the tolerability and safety of Flebogamma®DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients
Laia Alsina,Andreas Mohr,Maria Montañés,Xènia Oliver,Esperanza Martín,Jaime Pons,Elizabeth Drewe,Jens Papke,Georg Günther,Ronnie Chee,Mark Gompels
Pharmacology Research & Perspectives.2017;5(5)e00345
[DOI]
26Improvement in the Analysis of Vaccine Adverse Event Reporting System Database
Lili Zhao,Sunghun Lee,Rongxia Li,Edison Ong,Yongqun He,Gary Freed
Statistics in Biopharmaceutical Research.2020;12(3)303
[DOI]
27Pharmacovigilance Reports Received from Children and Young People, and Development of Information to Aid Future Reporting from this Age Group
Nikita Bhoombla,Jennifer Preston,Jenny Ainsworth,Helena Bird,Mitul Jadeja,Charlotte King,Daniel B. Hawcutt
Pediatric Drugs.2020;22(3)335
[DOI]
28Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review
Kazeem A. Oshikoya,Gerold T. Wharton,Debbie Avant,Sara L. Van Driest,Norman E. Fenn,Allison Lardieri,Edwin Doe,Beena G. Sood,Carol Taketomo,Phuong Lieu,Lilly Yen,Ann W. McMahon
Pediatric Drugs.2019;21(1)47
[DOI]
  Feedback 
  Subscribe